baber/WOPTO huggingface dataset:
Patent AU-2019261721-A1 (AU)
Title: A pressure regulator
Inventor: LAMBERT MICHAEL
IPC: H04R1/44
Filed: 2019-11-06
Abstract: A PRESSURE REGULATOR The present invention relates to a pressure regulator and in particular to a closed active pressure regulator gas coupled to an acoustic device which is disposed underwater. An acoustic device, such as a speaker (6), can be deployed underwater for many uses such as guiding fish, providing entertainment etc. However, as the depth of the acoustic device or underwater speaker increases, the external pressure increases proportionally. This pressure increase affects the acoustic response of the underwater speaker due to the external and internal differential pressure. As such the effectiveness of the speaker is reduced. Accordingly, the pressure regulator comprising an internal pressure sensor (1), a valve (7), and a gas supply each coupled to a processor (3), at least said valve (7), gas supply and processor disposed within a fluid tight housing (9), said pressure regulator including an external pressure sensor coupled to the processor (3) though the housing (9), whereby said pressure regulator is gas coupled to an acoustic device disposed underwater, said acoustic device contained within a pressure sealed and fluid tight container, said pressure regulator is a closed active system for removing gas from the container to the gas supply or supplying the gas from the gas supply to the container thereby regulating the pressure in the container. Figure 1 Pressure Vs Depth 0 10 20 30 40 50 60 Depth/ rn - Hydrostatic Pressure ---- Acoustic Chamber Pressure Figure 2
Patent AU-2019261986-A1 (AU)
Title: Combination therapy of a chimeric antigen receptor (CAR) T cell therapy and a kinase inhibitor
Inventor: FRANKEL STANLEY R
IPC: A61K35/17
Filed: 2019-04-30
Abstract: Provided are combination therapies involving immunotherapies e.g., a chimeric antigen receptor (CAR) T cell therapy, and the use of a kinase inhibitor, e.g., a BTK/lTK inhibitor, e.g. Ibrutinib, for treating subjects having cancers, such as certain B cell malignancies, and related methods, compositions, uses and articles of manufacture. The CAR T cell therapy includes cells that express recombinant receptors such as anti-CD19 CARS. In some embodiments, the B-cell malignancy is a non-Hodgkin lymphoma (NHL), such as relapsed or refractory NHL or specific NHL subtype.
Patent AU-2019262599-A1 (AU)
Title: KRAS G12C inhibitors and methods of using the same
Inventor: WURZ RYAN PAUL
IPC: A61K45/06
Filed: 2019-05-03
Abstract: Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
Patent AU-2019293644-A1 (AU)
Title: Three-dimensional microfluidics devices for the delivery of actives
Inventor: ALARY MARC
IPC: A61K9/70
Filed: 2019-06-28
Abstract: A dermal delivery device includes a film having first and second outwardly facing major surfaces; at least one liquid reservoir contained within the film; at least one microfluidic channel having a transverse dimension between about 100 nm and 0.5 mm disposed within the film and in fluid communication with the at least one liquid reservoir; and at least one outlet port operatively connected to the first outwardly facing major surface of the film in fluid communication with the at least one microfluidic channel.
Patent AU-2019334574-A1 (AU)
Title: Inhibitors of glucose transporters (GLUTs)
Inventor: WALDMANN HERBERT
IPC: A61P3/00
Filed: 2019-09-05
Abstract: The present invention relates to 2,6-methanobenzo[g][1]oxacin-4-onecompounds and their analog compounds and pharmaceutically acceptable salts thereof as selective inhibitor of glucose transporters 1 and 3 (GLUTs 1 and 3), to methods of preparing said compounds, and to the use thereof as pharmaceutically active agents, especially for the prophylaxis and/or treatment of metabolic diseases, immunological diseases, autoimmune diseases, inflammation, graft versus host disease, cancer, and metastasis thereof. Furthermore, the present invention is directed to pharmaceutical composition comprising at least one of 2,6-methanobenzo[g][1]oxacin-4-one compounds and their analog compounds.
Patent AU-2019351689-A1 (AU)
Title: Method, system and apparatus for object detection in point clouds
Inventor: YU YUANHAO
IPC: G06T7/70
Filed: 2019-09-10
Abstract: A method of detecting objects on a support structure includes: obtaining a point cloud of the support structure supporting an object; obtaining a position of a back of the support structure in the point cloud; discarding a portion of the point cloud based on the position of the back of the support structure; generating a three-dimensional occupancy grid from the point cloud, the occupancy grid having a plurality of cells each indicating whether the cell is one of occupied and unoccupied; identifying a contiguous region of occupied cells in the occupancy grid corresponding to the object; and generating a detected object position based on the contiguous region.
Patent AU-2019361359-A1 (AU)
Title: New uses of a 5-HT4 receptor agonist
Inventor: NIROGI RAMAKRISHNA
IPC: A61P25/28
Filed: 2019-10-17
Abstract: The present invention relates to new uses of a 5-HT4 receptor agonist, specifically Isopropyl-3 - { 5- [ 1 -(3 -methoxypropyl) piperidin-4-yl] - [ 1,3,4] oxadiazol-2-yl } - 1 H- indazole (Compound- 1) or a pharmaceutically acceptable salts thereof, for the treatment of dementia due to menopause, senile dementia, cognitive deficits associated with schizophrenia, depression, chemotherapy-induced cognitive impairment, and behavioral and psychological symptoms of dementia such as apathy/indifference, agitation, aggression, depression, anxiety, irritability/lability, dysphoria, aberrant motor behavior, delusions, hallucinations, elation/euphoria, psychosis, disinhibition, sleep and night time behavior disorders or appetite and eating disorders. The present invention further provides use of the said compounds in the manufacture of medicament intended for the treatment of the disorders described herein.
Patent AU-2019386569-A1 (AU)
Title: Vegan potato emulsion
Inventor: TORNBERG EVA
IPC: A23C11/10
Filed: 2019-11-25
Abstract: The present invention is related to a vegan, potato emulsion comprising heat treated potato in an amount of 0.5 – 20% by weight. The emulsion further comprises at least one sugar in an amount of 0 – 5 % by weight; at least one vegetable emulsifier in an amount of 0.09 – 1.0 by weight; at least one oil in an amount of 0.50 - 6 % by weight; at least one added vegetable protein in an amount of 0.20 – 3 % by weight; and water adding up to 100 % by weight. The emulsion has an oil droplet size D[3,2] of 0.1 – 10 µm. The potato emulsion is whitish, and is whippable providing a foam.
Patent AU-2019396151-A1 (AU)
Title: Safety lock structure for packaging box
Inventor: CHO TAI YUNG TITUS
IPC: B65D51/04
Filed: 2019-06-24
Abstract: A child-proof container, comprising a lid (10) and a container body (20) having a neck finish (21). An outer thread is provided on the outer wall of the neck finish, and an inner thread is provided on the inner wall of the lid. At least two pressing parts (13) are provided on the side wall of the lid. Elastic snaps (11) are provided on the inner walls of the pressing parts. Stop parts (23) corresponding to the elastic snaps are provided on the upper end face of the container body. When the lid is screwed onto the container body, the elastic snaps and the stop parts are engaged to each other. When the lid needs to be opened, the container body must be held with one hand and the pressing parts must be pressed with the other hand to disengage the elastic snaps and the stop parts from each other while rotating the lid to open same. Due to limitations of the size of the hands of a child, a child would be unable to press the two pressing parts with one hand, and thus unable to open the lid, such that the child can be prevented from mistakenly eating an object in the container body.
Patent AU-2019396628-A1 (AU)
Title: Improved semi-closed cycle with turbo membrane O2 source
Inventor: DUNN PAUL M
IPC: F01K25/08
Filed: 2019-12-16
Abstract: Disclosed is an improved method and system of operating the semi-closed cycle, which both reduces parasitic loads for oxygen generation and for gas clean up, while also reducing capital cost of the gas clean, up plant (reduced drying requirement) and of the oxygen plant (enabling membranes vs. mole sieves). The invention is applicable to piston or turbine engines, and results in a near fully non-emissive power system via the Semi-Closed Cycle (SCC), in a manner which both captures carbon in the form of carbon dioxide, CO2, and in a manner which improves the efficiency and cost effectiveness of prior disclosures. The captured carbon is of a purity and pressure directly suitable for Enhanced Oil Recovery (EOR), sequestration, or industrial use.
Patent AU-2020200029-A1 (AU)
Title: Method for removing bacteria from blood using high flow rate
Inventor: MCCREA KEITH
IPC: A61M1/36
Filed: 2020-01-03
Abstract: The present invention provides methods for removing a significant amount of bacteria (e.g., gram-negative bacteria and gram-positive bacteria, including bacteria with no or low affinity for heparan sulfate) from whole blood, serum or plasma using an adsorption media. The method can be used in extracorporeal treatments involving high volumetric flow rates and high linear flow rates.
Patent AU-2020200573-A1 (AU)
Title: Process for extraction and production of lithium salt products from brine
Inventor: MISLAN MICHAEL
IPC: C22B26/12
Filed: 2020-01-28
Abstract: A method for extracting lithium from brine, said method comprising the steps of: providing a brine 
containing lithium; processing the brine to remove contaminants; submitting the brine to an electrochemical 
extraction of lithium; disposing of the lithium-depleted brine; adding water to the extracted lithium to create 
a lithium solution; performing an electrolytic alkylation on the lithium solution; exposing the lithium 
solution to crystallization and evaporation; and recovering the lithium salt resulting therefrom.  
25
FIGURES 
Contaminants Fresh Water 
Lithium Brine Electrochemical Electrolytic Crystallization & Lithium Salt 
Containing Brine Pre-Processing Extraction Alkalization - Evaporation Unit Product 
Operations 
Lithium Depleted 
Brine to Disposal 
Figure 1 
Contaminants H2 Gas 
Electrolytic Cytliain 
Brine Electrochemical Electrochemical lAcdifiction+ Electrolytic Crystallization& 
Pre-Processing Alkalization Extraction Alkalization EvaporationUnit 
Lithium Recovery Operations 
Lithium Fresh Water Lithium Depleted Lithium Salt 
Containing Brine Brine to Disposall Product 
Figure 2 
Contaminants Fresh Water 
Brine Supercapacitor Electrochemical Electrolytic Crystallization & Lithium Salt 
Pre-Processing Etrctin Extraction Alkalization EvaporationUnit Product 
Extraction Operations 
Lithium Lithium Depleted 
Containing Brine Brine to Disposal 
Figure 3 
26
Patent AU-2020201553-A1 (AU)
Title: Headgear for patient interface
Inventor: MCLAREN MARK ARVIND
IPC: A61M16/06
Filed: 2020-03-03
Abstract: An interface includes a mask. The mask includes a frame and a seal supported by the frame. Headgear is connected to the mask. The interface includes at least one of (i) an adjustment mechanism that can be set to a use length for a loop defined by the mask and the headgear; and (2) a break-fit assembly that can selectively lengthen the loop defined by the mask and the headgear and return to the use length. -42-
Patent AU-2020202799-A1 (AU)
Title: Method, device and system for determining an arc on a power transmission line
Inventor: FRANKENBERG ROBERT
IPC: H02H3/40
Filed: 2020-04-28
Abstract: Method for determining a line property in the form of an arc on a power transmission line 
(K1-K3, L1-L3), wherein at least one test signal (Ul 1) is coupled into the power transmis
sion (K1-K3, L1-L3) and an interference signal at an interference point (100), which is 
formed by the arc, is generated along the power transmission line (K-K3, L1-0L3) with 
the aid of the at least one test signal (Ul 1), which interference signal is acquired as at least 
one measuring signal (U12), and the line property is determined from the at least one 
measuring signal (U12), wherein the line property is determined by detecting at least one 
intermodulation product from the at least one test signal (Ul 1) and the mains signal of the 
power transmission line (K1-K3, L1-L3) in the at least one measuring signal (U22).  
Fig. 1
1/3 
FIG 1 101 100 
SHV/MV---L 
10K2 Li 
---- K3 TO- --L 
10 K2cli-J C12- C13--2 
120Ti 
F201 10 100 
i Ki ----L 
L21 L22 L23 
IG 240 101N42
Patent AU-2020214275-A1 (AU)
Title: Dezocine derivative and medical use thereof
Inventor: SHAO LIMING
IPC: C07C215/64
Filed: 2020-01-31
Abstract: Provided are a dezocine derivative of formula I or a tautomer, optical isomer, oxynitride, solvate, pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutical composition comprising the same, a preparation method therefor, and a medical use thereof, the structure of the formula I is as follows:
Patent AU-2020233677-A1 (AU)
Title: A pipe wear monitoring system and method of use thereof
Inventor: EAMES COLIN NEIL
IPC: F16L57/06
Filed: 2020-03-05
Abstract: (Figure 2) 
The present invention relates to a system and method for monitoring wear in pipes, particularly 
irregular wear in pipelines transporting abrasive fluids. The system includes a plurality of wear 
sensors spaced along a length of a pipe. Each wear sensor is configured to detect wear in a 
wall of the pipe. The system further includes at least one remotely accessible server operatively 
connected to the sensors for receiving and monitoring data output from said sensors. The server 
is configured to alert an operator when said data received from any one of the plurality of sensors 
is indicative of irregular wear in the wall of the pipe.
Patent AU-2020240059-A1 (AU)
Title: Pyridazinones and methods of use thereof
Inventor: REILLY JOHN FRANCIS
IPC: A61K31/519
Filed: 2020-03-18
Abstract: Disclosed are therapeutic methods, e.g., of treating kidney diseases, using compounds of Formula (A) in combination with a second therapeutic agent.
Patent AU-2020241413-A1 (AU)
Title: Delegated administration of permissions using a contactless card
Inventor: RULE JEFFREY
IPC: G06F21/35
Filed: 2020-03-19
Abstract: Delegated administration of permissions using a contactless card. In one example, a permissions module may receive a request from a first account to grant a second account access to a computing resource. The permissions module may receive permissions data of the first account from a contactless card and encrypted data generated by the contactless card. The permissions module may transmit the permissions data and the encrypted data to an authentication server, which may verify the encrypted data based at least in part on the private key, and determine, based on the permissions data, that the first account has permissions to grant access to the computing resource. The permissions module may receive, from the authentication server, an indication of the verification of the encrypted data and a permissions vector associated with the second account, the permissions vector reflecting the grant of access to the computing resource to the second account.
Patent AU-2020261267-A1 (AU)
Title: Techniques for dynamic control of a Magnetic Resonance Imaging system
Inventor: SACOLICK LAURA
IPC: G01R33/54
Filed: 2020-03-26
Abstract: Techniques are described for controlling components of a Magnetic Resonance Imaging (MRI) system with a single controller, such as a Field Programmable Gate Array (FPGA), by dynamically instructing the controller to issue commands to the components using a processor coupled to the controller. According to some aspects, the controller may issue commands to the components of the MRI system whilst actively receiving commands from the processor to be later issued to the components.
Patent AU-2020280103-A1 (AU)
Title: Compositions and methods for CD33 modification
Inventor: LYDEARD JOHN
IPC: C12N15/113
Filed: 2020-05-22
Abstract: Some aspects of this disclosure provides, e.g., novel cells having a modification (e.g., insertion or deletion) in the endogenous CD33 gene. Some aspects of the disclosure provide compositions, e.g., gRNAs, that can be used to make such a modification.
Patent AU-2020290396-A1 (AU)
Title: EBS tractor control line to trailer system to improve transmission timing for an air brake system
Inventor: RIPLEY JOHN V
IPC: B60T7/20
Filed: 2020-06-05
Abstract: A brake control signal amplification system that is designed to assist with the compliance to the FMVSS-121 Safety Standard for an air braked vehicle is described which comprises a trailer control module (TCM) that provides pneumatic signal to a trailer of the vehicle, a tractor protection valve (TPV) that protects a tractor air brake system in the event of a pneumatic disconnection from the trailer, and a pilot relay valve (PRV) coupled between the TCM and the TPV, wherein the PRV amplifies a control signal received from the TCM and delivers an amplified control signal to the TPV. The TPV delivers the amplified control signal to a control coupling for a trailer portion of a vehicle and delivers an air supply to a supply coupling for the trailer of the vehicle.
Patent AU-2020292610-A1 (AU)
Title: Oncolytic adenovirus and checkpoint inhibitor combination therapy
Inventor: HEMMINKI AKSELI
IPC: C07K16/28
Filed: 2020-06-12
Abstract: The present invention relates to combination therapy with oncolytic viruses, particularly oncolytic adenoviruses, and checkpoint inhibitors for the treatment of cancer, particularly to a combination comprising (a) an oncolytic adenoviral vector encoding tumor necrosis factor alpha (TNFalpha) and/or interleukin-2 (IL-2) as a transgene and (b) one or more immune checkpoint inhibitors for use in the treatment of cancer.
Patent AU-2020315210-A1 (AU)
Title: Imidazo[4,5-C]pyridine derivatives as Toll-like receptor agonists
Inventor: AHMAD OMAR
IPC: A61P35/00
Filed: 2020-07-14
Abstract: The present invention relates to imidazo-pyridinyl compounds, or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject.
Patent AU-2020315959-A1 (AU)
Title: Seam seal for wine in beverage cans
Inventor: STOWITTS ADAM
IPC: B65D25/14
Filed: 2020-07-23
Abstract: A can end (10) for a two-piece beverage container (1) has a public side (32) opposite a product side (34). A cured coating (76) is on the product side (34) of the can end (10) and forms a substantially continuous thin layer thereon. A circumferential curl (12) is centered about a longitudinal axis (50). A circumferential chuckwall (14) extends downwardly from the curl (12). A circumferential U-shaped countersink (16) is located downwardly from the chuckwall (14). The countersink (16) has an annular bead defining a lowermost vertical extent of the can end (10). A center panel (18) is located radially inwardly from the countersink (16) and is centered about the longitudinal axis (50). The center panel (18) has a means for providing an opening in the can end (10). A circumferential second coating (92) forms an annular layer on the product side (34) of the circumferential curl (12) and the cured coating (76). The second coating (92) provides a layer on one or more fractures in the cured coating (76).
Patent AU-2020340518-A1 (AU)
Title: Polymers for spray drift control of pesticide spray
Inventor: ANDERSON TIMOTHY H
IPC: A01N47/24
Filed: 2020-08-26
Abstract: An agricultural composition comprising at least one cationic polymer and an agriculturally active agent where the cationic polymer has at least one quaternary nitrogen atom. The agricultural composition is used in agricultural spray operations and demonstrates effective reduction of driftable droplets.
Patent AU-2020342172-A1 (AU)
Title: Composition and method for extinguishing fire
Inventor: CHOO HIOW SAN
IPC: A62D1/00
Filed: 2020-09-04
Abstract: The present invention relates to a composition for extinguishing fire, comprising an aqueous solution of a surfactant and a deliquescent anionic salt. A method for extinguishing fire is also disclosed. The method (100) comprises mixing a surfactant and a deliquescent anionic salt in water to form an aqueous solution (110) and spreading the aqueous solution over a burning surface (120).
Patent AU-2020347797-A1 (AU)
Title: Forecast of MRI images by means of a forecast model trained by supervised learning
Inventor: ROHRER MARTIN
IPC: A61K49/10
Filed: 2020-09-14
Abstract: The invention relates to the field of accelerating MRI examinations and in particular to a method, a system, a computer program product, a use, a contrast agent for use, and a kit.
Patent AU-2020350090-A1 (AU)
Title: Pressing-force transmission means, pressing tool, system and method for producing a tight connection between a press-connector and a workpiece
Inventor: ROSENTHAL JÖRG
IPC: B25B27/10
Filed: 2020-09-02
Abstract: The invention relates to a system (2) for producing a tight connection between a press-connector (10) and a workpiece (4), in particular a pipe, preferably a plastics pipe, using a pressing tool (8) to press a press-connector (10) and using a pressure tool (12) for driving the pressing tool (8). The pressure tool (12) is designed to output a hydraulic pressure at a pressure generation location (16). The pressing tool (8) is designed to receive a hydraulic pressure at a pressing location (18) and to press a press-connector (10) accordingly. The pressure tool (12) and the pressing tool (8) are connected via a hydraulic pressure-transferring connection (14), wherein the pressure generation location (16) and the pressing location (18) are remote from one another. The invention also relates to a corresponding method for producing a tight connection between a press-connector (10) and a workpiece (4), in particular a pipe made of yielding material, preferably a plastics pipe, and a pressing-force transmission means and a pressing tool.
Patent AU-2020351308-A1 (AU)
Title: Distributed blockchain-type implementations configured to manage tokenized digital assets and improved electronic wallets, and methods of use thereof
Inventor: PROKOPENYA VIKTOR
IPC: H04L9/32
Filed: 2020-09-10
Abstract: In some embodiments, the present description provides a computer-based system having a dual-exchange cryptographically-secured platform (DECSP); where the DECSP includes: a first-type cryptographically-secured platform (first-type CSP) and a second-type cryptographically-secured platform (second-type CSP); where the first-type CSP includes a first computing device; where the second-type CSP includes a second computing device; where the first computing device is connected to a blockchain and configured to issue crypto-tokens associated with a non-crypto asset, perform blockchain-based activities, and automatically transmit an instruction associated with the non-crypto asset to a second computing device in response to an issuance of the crypto-token by the first computing device; where the second computing device is configured to: receive the instruction associated with the one non-crypto asset from the first computing device and automatically communicate with a non-crypto asset electronic marketplace to execute a transaction associated with the non-crypto asset to obtain a position in the non-crypto asset.